Enanta Pharmaceuticals (ENTA) Payables (2012 - 2026)
Enanta Pharmaceuticals posted quarterly Payables of $4.4 million for Q1 2026, down 8.26% year-on-year from $4.8 million in Q1 2025, and up 131.46% on a QoQ basis from $1.9 million in Q4 2025.
Enanta Pharmaceuticals (ENTA) has 15 years of Payables data on file, last reported at $4.4 million in Q1 2026.
- For the quarter ending Q1 2026, Payables fell 8.26% year-over-year to $4.4 million; the trailing twelve-month figure through Mar 2026 stood at $4.4 million (down 8.26% YoY), and the FY2025 full-year result was $1.9 million, down 75.66% from the prior year.
- Payables for Q1 2026 stood at $4.4 million, up from $1.9 million in the prior quarter.
- Across five years, Payables topped out at $11.8 million in Q1 2023 and bottomed at $1.2 million in Q2 2022.
- The 5-year median for Payables is $4.8 million (2025), against an average of $5.7 million.
- The widest annual swing landed in 2022, when Payables plunged 78.88%; it then jumped 537.11% in 2023.
- A 5-year view of Payables shows it stood at $4.4 million in 2022, then jumped by 114.29% to $9.3 million in 2023, then slumped by 49.32% to $4.7 million in 2024, then plunged by 60.11% to $1.9 million in 2025, then jumped by 131.46% to $4.4 million in 2026.
- The last three Payables figures came in at $4.4 million (Q1 2026), $1.9 million (Q4 2025), and $1.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 300,549.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1.05 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 83.00 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 10.62 Mn |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 8.69 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 489.30 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 1.03 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 126.63 Mn |
| 10 | Enanta Pharmaceuticals | 367.22 Mn | 203.44 Mn | - | 4.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.36 Mn |
| Dec 31, 2025 | 1.89 Mn |
| Sep 30, 2025 | 1.95 Mn |
| Jun 30, 2025 | 3.55 Mn |
| Mar 31, 2025 | 4.76 Mn |
| Dec 31, 2024 | 4.73 Mn |
| Sep 30, 2024 | 8.00 Mn |
| Jun 30, 2024 | 10.68 Mn |
| Mar 31, 2024 | 6.73 Mn |
| Dec 31, 2023 | 9.33 Mn |
| Sep 30, 2023 | 4.10 Mn |
| Jun 30, 2023 | 7.93 Mn |
| Mar 31, 2023 | 11.76 Mn |
| Dec 31, 2022 | 4.35 Mn |
| Sep 30, 2022 | 6.00 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Mar 31, 2022 | 5.99 Mn |
| Dec 31, 2021 | 7.84 Mn |
| Sep 30, 2021 | 9.54 Mn |
| Jun 30, 2021 | 5.90 Mn |
| Mar 31, 2021 | 5.70 Mn |
| Dec 31, 2020 | 6.31 Mn |
| Sep 30, 2020 | 5.74 Mn |
| Jun 30, 2020 | 6.07 Mn |
| Mar 31, 2020 | 5.95 Mn |
| Dec 31, 2019 | 6.60 Mn |
| Sep 30, 2019 | 6.69 Mn |
| Jun 30, 2019 | 6.50 Mn |
| Mar 31, 2019 | 8.88 Mn |
| Dec 31, 2018 | 5.62 Mn |
| Sep 30, 2018 | 4.75 Mn |
| Jun 30, 2018 | 4.90 Mn |
| Mar 31, 2018 | 4.70 Mn |
| Dec 31, 2017 | 3.27 Mn |
| Sep 30, 2017 | 3.71 Mn |
| Jun 30, 2017 | 5.49 Mn |
| Mar 31, 2017 | 4.06 Mn |
| Dec 31, 2016 | 1.95 Mn |
| Sep 30, 2016 | 3.38 Mn |
| Jun 30, 2016 | 2.04 Mn |
| Mar 31, 2016 | 2.57 Mn |
| Dec 31, 2015 | 2.77 Mn |
| Sep 30, 2015 | 1.54 Mn |
| Jun 30, 2015 | 733,000.00 |
| Mar 31, 2015 | 2.34 Mn |
| Dec 31, 2014 | 567,000.00 |
| Sep 30, 2014 | 1.87 Mn |
| Jun 30, 2014 | 1.28 Mn |
| Mar 31, 2014 | 2.04 Mn |
| Dec 31, 2013 | 840,000.00 |
| Sep 30, 2013 | 350,000.00 |
| Jun 30, 2013 | 221,000.00 |
| Mar 31, 2013 | 23,000.00 |
| Sep 30, 2012 | 1.33 Mn |